The purpose of this study was to determine the safety and efficacy of Kovacaine Mist (3% tetracaine HCl with 0.05% oxymetazoline HCl) for anesthesia of the maxillary teeth for dental procedures.
The primary objective of this single-center, randomized, double-blind, active-controlled, parallel-group study was to determine if Kovacaine Mist provided anesthesia of the maxillary teeth sufficient for the performance of dental procedures. Secondary objectives included a determination of whether Kovacaine Mist provided anesthesia of the soft tissue and to evaluate the safety and tolerability of Kovacaine Mist and sham injection as compared to sham nasal spray and 2% lidocaine hydrochloride with 1:100,000 epinephrine submucosal injection and as determined by changes in vital signs and reports of side effects and adverse events.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
DOUBLE
Enrollment
45
1 sham injection along with 3 sprays of Kovacaine Nasal Spray in each nostril; a 4-minute interval between every set of sprays. The total dose of 3% tetracaine HCL with 0.05% oxymetazoline HCL was 18 mg/0.3 mg.
Each subject received both an injection along with 3 sprays of isotonic saline sham in each nostril; a 4-minute interval between every set of sprays.
University of Buffalo
Buffalo, New York, United States
Pulpal Anesthesia
Number of participants who did not need rescue anesthesia to complete the study dental procedure, i.e. Kovacaine provided enough pulpal anesthesia to complete a dental procedure.
Time frame: Continuous throughout dental treatment period (up to 60 minutes)
Soft Tissue Anesthesia Duration
Assessment of pain using a Rotadent sensor probe, applying up to 20 grams/cm\^2 at the tissue site. At each time point, participants were asked if they felt pain from the sensor probe at each site location in the mouth. The four sites were: * Site 1: Distal to the apex of the tooth in the position of the maxillary first premolar at the deepest point in the buccal vestibule * Site 2: Apical to the maxillary lateral incisor at the deepest point in the labial vestibule * Site 3: Incisive papilla * Site 4: At the confluence of the alveolar process and hard palate medial to the maxillary second premolar (near the greater palatine foramen)
Time frame: Baseline, 15, 20, 30, 40, 50, 60, 80, 100, 120 minutes
Maximum Change in Pulse From Baseline
Maximum change from Baseline at any time point.
Time frame: Baseline, 15, 20, 30, 40, 50, 60, 120 minutes
Maximum Change in Blood Pressure From Baseline
Maximum change from Baseline at any time point.
Time frame: Baseline, 15, 20, 30, 40 50, 60, 120 minutes
Maximum Change in Pulse Oximetry From Baseline
Maximum change from Baseline at any time point
Time frame: Baseline, 15, 20, 30, 40, 50, 60, 120 minutes
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.